Thank you, Chair.
Thank you, witnesses, for coming to our committee again and giving your expert opinions.
Dr. Plummer, we've already established that you're an esteemed scientist, physician, and researcher who has conducted in-depth studies and research related to HIV/AIDS. You're well versed in the existing climate related to HIV clinical trials and have likely listened to the witness testimony from experts such as Dr. Gerson, who disavows the government's thinking on the cancellation of this project.
Given your experience, do you agree with Dr. Gerson's assessment of manufacturing capacity and the notion that has been asserted by opposition members that there was greater emphasis on the quantity of manufacturing facilities, as opposed to measuring the quality of such facilities?